Better Buy: Crispr Therapeutics vs. bluebird bio [The Motley Fool]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: The Motley Fool
bluebird bio(NASDAQ:BLUE 00Bluebird has also been outperformed by one of its competitors in the gene-editing industry, namelyCRISPR TherapeuticsNASDAQ:CRSPCRISPR Therapeutics has a promising pipeline candidateCRISPR Therapeutics currently has no approved products. However, the company has a very promising pipeline candidate called CTX00. This product is a potential treatment for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD), both of which are blood disorders. Last year, CRISPR Therapeutics reported positive results from a clinical trial investigating the safety and efficacy of CTX00 as a treatment for TDT and SCD. The trial involved two patients, one with TDT and one with SCD.Image Source: Getty Images.The patient with TDT required 6. blood transfusions per year before receiving the treatment, but this patient was transfusion-independent nine months after the treatment. Also, the SCD patient experienced an average of seven vaso-occlusive crises (VOC, a sid
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (CRSP) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- The cutting-edge treatment that could lower dangerously high cholesterol [MSNBC.com]MSNBC.com
- A one-time treatment tweaked their genes — and lowered their cholesterol [MSNBC.com]MSNBC.com
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/2/26 - Form PRE
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website